Invesco DWA Healthcare Momentum ETF (PTH)

NASDAQ: PTH · IEX Real-Time Price · USD
+0.30 (0.23%)
At close: Aug 8, 2022 3:59 PM
-0.04 (-0.03%)
After-hours: Aug 8, 2022 4:15 PM EDT
Assets $261.58M
NAV $130.14
Expense Ratio 0.60%
PE Ratio 39.00
Shares Out 2.01M
Dividend (ttm) n/a
Dividend Yield n/a
Ex-Dividend Date Dec 20, 2013
1-Year Return -24.05%
Volume 9,227
Open 130.11
Previous Close 130.14
Day's Range 129.27 - 131.37
52-Week Low 105.92
52-Week High 175.85
Beta 0.95
Holdings 35
Inception Date Oct 12, 2006

About PTH

The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. The underlying index is composed of at least 30 securities of companies in the healthcare sector that have powerful relative strength or momentum characteristics.

Asset Class Equity
Sector Biotech
Region North America
Issuer Invesco
Stock Exchange NASDAQ
Ticker Symbol PTH
Index Tracked Dorsey Wright Healthcare Technical Leaders Index

Top 10 Holdings

37.79% of assets
Name Symbol Weight
Lantheus Holdings LNTH 4.63%
UnitedHealth Group UNH 4.22%
The Ensign Group ENSG 4.03%
Molina Healthcare MOH 4.02%
Evolent Health EVH 3.95%
Acadia Healthcare Company ACHC 3.84%
Cogent Biosciences COGT 3.42%
Centene CNC 3.34%
Eli Lilly and Company LLY 3.19%
TransMedics Group TMDX 3.16%
View More Holdings


5 Undervalued ETFs to Buy for Second Half 2022

Persistent high inflation and an economic downturn caused by a hawkish Fed continued to weigh on investor sentiment. This has made the stocks cheaper, compelling investors to buy the dip.


Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

Sector ETF report for PTH

ETFs With Largest Assets Lost In 2021

Which funds struggled to retain assets this year?

Spice Up Your Healthcare Exposure with Some Momentum

The healthcare sector has been one of the mainstays for stable growth options in various market environments. Add some momentum to the mix to get the Invesco DWA Healthcare Momentum ETF (PTH).

Up 85%, Invesco's ‘PTH' Is Hitting the Right Healthcare Angles

Not surprisingly, the coronavirus pandemic is stoking increases in global healthcare spending. The Invesco DWA Healthcare Momentum Portfolio (NASDAQ: PTH) is among several exchange traded funds levered ...

Best Growth ETFs for Q2 2021

The best growth ETFs for Q2 2021 are OGIG, PTF, and PTH.

Other symbols: OGIGPTF

An ETF Retirement Portfolio for 2021

Here are a few ETF strategies that could be considered in a retirement portfolio.

4 Interesting ETFs for More Adventurous Investors

Today's exchange-traded funds are diverse investment vehicles that can offer big returns to investors. Here are four ETFs to consider.

Other symbols: ICLNIPAYPGJ

Best Healthcare ETFs for Q1 2021

The best healthcare ETFs for Q1 2021 are ARKG, PTH, and KURE.

Other symbols: ARKGKURE

Best Growth ETFs for Q1 2021

The best growth ETFs for Q1 2021 are OGIG, PTH, and PTF.

Other symbols: OGIGPTF

5 Reasons Why Investors Should Consider a Healthcare ETF

Healthcare sector-related exchange traded funds provide access to a market segment that is constantly innovating to improve our quality of life. “Health care presents the opportunity to invest in compan...

These ETFs Have Provided Stellar Returns the Last 10 Years

An article in Financial Planning listed 20 ETFs that have been the head of their class the last 10 years. Some of those funds featured iShares ETFs with technology and healthcare being top performers in...

Other symbols: PNQIXNTK

Trump vs. Biden First Presidential Debate: ETFs in Focus

After months of campaign, President Donald Trump and Democratic nominee Joe Biden will come face-to-face on debate stage on Sep 30 in Cleveland.

3 Health Care ETFs Where Components Are Enduring Downgrades

After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing.

Other symbols: BTECPBE

18 ETFs That Could Help You Send Your Kids to College

Here are a bunch of exchange-traded funds with above-average growth rates. See which ones most inspire your confidence.

Healthcare ETFs, Stocks That Gained Double Digits Last Week

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.


3 ETFs To Play Gilead's $21B Immunomedics Takeover

Biotechnology mergers and acquisitions appear to be back in a big way with news that Gilead Sciences (NASDAQ: GILD) is acquiring Immunomedics (NASDAQ: IMMU) for $21 billion.

Other symbols: BTEC

Powerful PTH can Regain Momentum

Biotechnology and healthcare ETFs recently retreated, perhaps a sign of frustration on the coronavirus vaccine front or just a case of election year jitters. Either way, the Invesco DWA Healthcare Momen...

5 ETFs Jump After Three-Day Rout: Will The Rally Last?

We have highlighted ETFs that were at the forefront of the market rebound on Sep 9 and will continue to do so if market sentiments remain positive.

Other symbols: ARKQCNCRPBW

Specialty biotech funds jump on promising coronavirus, funding news

Specialized health-care exchange-traded funds outperformed the broader stock market Wednesday even as stocks rebounded from a sell-off that left the Nasdaq Composite Index in correction territory. The ...

Other symbols: CNCR

ETF Winners & Losers From Wall Street's Worst Day Since June

After a massive rally, Wall Street suffered its worst day in almost three months as investors' dumped the high-flying technology stocks.


Best Healthcare ETFs for Q4 2020

The best healthcare ETFs for Q4 2020 are ARKG, KURE, and PTH.

Other symbols: ARKGKURE

ETFs Set to Surge on Virtual Healthcare Deal

The ongoing boom in online care and consultations has led to merger & acquisition activity in the telehealth services space.

Other symbols: AIEQIHF

6 ETF Picks for Historically Downbeat August

A consensus carried out from 1950 to 2019 shows that August posted an average equity return of negative 0.26%.


COVID-19 Vaccine Push Brings Hope: Stock & ETF Beneficiaries

There are at least a hundred candidates in the COVID-19 vaccine race globally. However, few companies like Moderna, Pfizer and AstraZeneca are showing considerable hope.